China Traditional Chinese Medicine Holdings Co. Limited (0570.HK)
HKD 2.02
(0.0%)
HKD 2.02
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 2.55 Billion CNY | 10.39% |
| 2022 | 2.16 Billion CNY | -35.69% |
| 2021 | 3.59 Billion CNY | 11.98% |
| 2020 | 3.15 Billion CNY | 5.6% |
| 2019 | 3.04 Billion CNY | 17.69% |
| 2018 | 2.65 Billion CNY | 17.83% |
| 2017 | 2.19 Billion CNY | 23.77% |
| 2016 | 1.71 Billion CNY | 94.12% |
| 2015 | 921.02 Million CNY | 37.15% |
| 2014 | 670.79 Million CNY | 100.28% |
| 2013 | 341.03 Million CNY | 22.48% |
| 2012 | 271.52 Million CNY | 110.51% |
| 2011 | 128.88 Million CNY | -12.72% |
| 2010 | 147.66 Million CNY | 13.36% |
| 2009 | 130.27 Million CNY | 64.39% |
| 2008 | 79.24 Million CNY | 32.42% |
| 2007 | 62.91 Million CNY | -32.46% |
| 2006 | 88.6 Million CNY | 111.64% |
| 2005 | -761.16 Million CNY | -1583.81% |
| 2004 | 51.29 Million CNY | -57.42% |
| 2003 | 120.46 Million CNY | -49.09% |
| 2002 | 236.65 Million CNY | 158.74% |
| 2001 | 91.46 Million CNY | 78.53% |
| 2000 | 51.23 Million CNY | -76.71% |
| 1999 | 220 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 453.86 Million CNY | -17.01% |
| 2024 Q2 | 453.86 Million CNY | 0.0% |
| 2023 Q1 | 663.66 Million CNY | 14.8% |
| 2023 Q3 | 546.86 Million CNY | -17.6% |
| 2023 FY | - CNY | 10.39% |
| 2023 Q4 | 546.86 Million CNY | 0.0% |
| 2023 Q2 | 663.66 Million CNY | 0.0% |
| 2022 Q2 | 530.01 Million CNY | 0.0% |
| 2022 Q1 | 530.01 Million CNY | -42.27% |
| 2022 FY | - CNY | -35.69% |
| 2022 Q4 | 578.12 Million CNY | 0.0% |
| 2022 Q3 | 578.12 Million CNY | 9.08% |
| 2021 Q3 | 918.06 Million CNY | 10.03% |
| 2021 Q4 | 918.06 Million CNY | 0.0% |
| 2021 FY | - CNY | 11.98% |
| 2021 Q1 | 834.36 Million CNY | -3.36% |
| 2021 Q2 | 834.36 Million CNY | 0.0% |
| 2020 FY | - CNY | 5.6% |
| 2020 Q3 | 863.39 Million CNY | 24.39% |
| 2020 Q2 | 694.09 Million CNY | 0.0% |
| 2020 Q4 | 863.39 Million CNY | 0.0% |
| 2020 Q1 | 694.09 Million CNY | -5.46% |
| 2019 Q4 | 734.18 Million CNY | 0.0% |
| 2019 Q2 | 754.91 Million CNY | 0.0% |
| 2019 Q1 | 754.91 Million CNY | 18.35% |
| 2019 FY | - CNY | 17.69% |
| 2019 Q3 | 734.18 Million CNY | -2.75% |
| 2018 Q4 | 637.86 Million CNY | 0.0% |
| 2018 FY | - CNY | 17.83% |
| 2018 Q3 | 637.86 Million CNY | -4.2% |
| 2018 Q2 | 665.81 Million CNY | 0.0% |
| 2018 Q1 | 665.81 Million CNY | 20.64% |
| 2017 FY | - CNY | 23.77% |
| 2017 Q4 | 551.9 Million CNY | 0.0% |
| 2017 Q1 | 529.92 Million CNY | 38.34% |
| 2017 Q3 | 551.9 Million CNY | 4.15% |
| 2017 Q2 | 529.92 Million CNY | 0.0% |
| 2016 Q1 | 422.56 Million CNY | 94.49% |
| 2016 FY | - CNY | 94.12% |
| 2016 Q4 | 383.05 Million CNY | 0.0% |
| 2016 Q3 | 383.05 Million CNY | -9.35% |
| 2016 Q2 | 422.56 Million CNY | 0.0% |
| 2015 Q4 | 217.27 Million CNY | 0.0% |
| 2015 Q1 | 170.46 Million CNY | -2.99% |
| 2015 FY | - CNY | 37.15% |
| 2015 Q2 | 170.46 Million CNY | 0.0% |
| 2015 Q3 | 217.27 Million CNY | 27.46% |
| 2014 Q4 | 175.71 Million CNY | 0.0% |
| 2014 FY | - CNY | 100.28% |
| 2014 Q3 | 175.71 Million CNY | 9.68% |
| 2014 Q2 | 160.21 Million CNY | 0.0% |
| 2014 Q1 | 160.21 Million CNY | 55.02% |
| 2013 Q2 | 58.07 Million CNY | 0.0% |
| 2013 Q4 | 103.35 Million CNY | 0.0% |
| 2013 Q3 | 103.35 Million CNY | 77.95% |
| 2013 FY | - CNY | 22.48% |
| 2013 Q1 | 58.07 Million CNY | -17.79% |
| 2012 Q1 | 66.62 Million CNY | 0.0% |
| 2012 Q2 | 66.62 Million CNY | 0.0% |
| 2012 Q3 | 70.19 Million CNY | 5.36% |
| 2012 Q4 | 70.64 Million CNY | 0.64% |
| 2012 FY | - CNY | 110.51% |
| 2011 Q1 | 30.33 Million CNY | 0.0% |
| 2011 FY | - CNY | -12.72% |
| 2011 Q4 | 66.62 Million CNY | 119.64% |
| 2011 Q3 | 30.33 Million CNY | 0.0% |
| 2011 Q2 | 30.33 Million CNY | 0.0% |
| 2010 Q4 | 30.33 Million CNY | -1.32% |
| 2010 FY | - CNY | 13.36% |
| 2010 Q3 | 30.74 Million CNY | 0.0% |
| 2010 Q1 | 30.74 Million CNY | 0.0% |
| 2010 Q2 | 30.74 Million CNY | 0.0% |
| 2009 Q3 | 26.07 Million CNY | 0.0% |
| 2009 Q1 | 26.07 Million CNY | 0.0% |
| 2009 Q2 | 26.07 Million CNY | 0.0% |
| 2009 Q4 | 30.74 Million CNY | 17.89% |
| 2009 FY | - CNY | 64.39% |
| 2008 Q1 | 13.31 Million CNY | 0.0% |
| 2008 FY | - CNY | 32.42% |
| 2008 Q4 | 26.07 Million CNY | 95.85% |
| 2008 Q3 | 13.31 Million CNY | 0.0% |
| 2008 Q2 | 13.31 Million CNY | 0.0% |
| 2007 Q3 | 15.43 Million CNY | 0.0% |
| 2007 Q4 | 13.31 Million CNY | -13.74% |
| 2007 FY | - CNY | -32.46% |
| 2007 Q1 | 15.43 Million CNY | 0.0% |
| 2007 Q2 | 15.43 Million CNY | 0.0% |
| 2006 Q1 | -85.52 Million CNY | 0.0% |
| 2006 FY | - CNY | 111.64% |
| 2006 Q4 | 15.43 Million CNY | 118.05% |
| 2006 Q3 | -85.52 Million CNY | 0.0% |
| 2006 Q2 | -85.52 Million CNY | 0.0% |
| 2005 Q2 | -190.33 Million CNY | 0.0% |
| 2005 Q4 | -85.52 Million CNY | 55.06% |
| 2005 Q3 | -190.33 Million CNY | 0.0% |
| 2005 Q1 | -190.33 Million CNY | 0.0% |
| 2005 FY | - CNY | -1583.81% |
| 2004 Q2 | 8.48 Million CNY | 0.0% |
| 2004 Q3 | 8.48 Million CNY | 0.0% |
| 2004 Q4 | -190.33 Million CNY | -2342.19% |
| 2004 FY | - CNY | -57.42% |
| 2004 Q1 | 8.48 Million CNY | 0.0% |
| 2003 Q1 | 21.76 Million CNY | 0.0% |
| 2003 FY | - CNY | -49.09% |
| 2003 Q4 | 8.48 Million CNY | -61.0% |
| 2003 Q2 | 21.76 Million CNY | 0.0% |
| 2003 Q3 | 21.76 Million CNY | 0.0% |
| 2002 Q2 | 44.2 Million CNY | 0.0% |
| 2002 Q3 | 44.2 Million CNY | 0.0% |
| 2002 FY | - CNY | 158.74% |
| 2002 Q4 | 21.76 Million CNY | -50.77% |
| 2002 Q1 | 44.2 Million CNY | 0.0% |
| 2001 Q2 | 7.11 Million CNY | 0.0% |
| 2001 Q1 | 7.11 Million CNY | 0.0% |
| 2001 FY | - CNY | 78.53% |
| 2001 Q4 | 44.2 Million CNY | 521.35% |
| 2001 Q3 | 7.11 Million CNY | 0.0% |
| 2000 Q2 | -4.58 Million CNY | 0.0% |
| 2000 Q1 | -4.58 Million CNY | 0.0% |
| 2000 FY | - CNY | -76.71% |
| 2000 Q4 | 7.11 Million CNY | 255.19% |
| 2000 Q3 | -4.58 Million CNY | 0.0% |
| 1999 Q2 | 28.67 Million CNY | 0.0% |
| 1999 Q3 | 28.67 Million CNY | 0.0% |
| 1999 Q4 | -4.58 Million CNY | -115.99% |
| 1999 FY | - CNY | 0.0% |
| 1999 Q1 | 28.67 Million CNY | 0.0% |
| 1998 Q4 | 28.67 Million CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 150.4 Million HKD | -1600.033% |
| Grand Pharmaceutical Group Limited | 2.96 Billion HKD | 13.811% |
| Extrawell Pharmaceutical Holdings Limited | -129.51 Million HKD | 2074.096% |
| Wai Yuen Tong Medicine Holdings Limited | 113.79 Million HKD | -2146.831% |
| Qianhai Health Holdings Limited | -50.22 Million HKD | 5190.384% |
| Lee's Pharmaceutical Holdings Limited | 109.82 Million HKD | -2228.218% |
| Essex Bio-Technology Limited | 418.37 Million HKD | -511.135% |
| Tongfang Kontafarma Holdings Limited | 76.63 Million HKD | -3236.486% |
| PuraPharm Corporation Limited | -26.16 Million HKD | 9870.526% |
| SSY Group Limited | 2.11 Billion HKD | -20.917% |
| JBM (Healthcare) Limited | 204.39 Million HKD | -1150.966% |
| Jacobson Pharma Corporation Limited | 429.92 Million HKD | -494.725% |
| China Resources Pharmaceutical Group Limited | 15.43 Billion HKD | 83.43% |